S. D. Glick, K. Rossman, S. Steindorf, I. M. Maisonneuve, and J. N. Carlson, Effects and after effects of ibogaine on morphine self-administration in rats, Eur. J. Pharmacol, pp.195-341, 1991.

E. D. Dzoljic, C. D. Kaplan, and M. R. Dzoljic, Effect of ibogaine on naloxone precipitated withdrawal syndrome in chronic morphine-dependent rats, Arch. Int. Pharmacodyn. Ther, pp.294-64, 1988.

S. L. Cappendijk and M. R. Dzoljic, Inhibitory effects of ibogaine on cocaine self-administration in rats, European Journal of Pharmacology, vol.241, issue.2-3, pp.261-266, 1993.
DOI : 10.1016/0014-2999(93)90212-Z

A. Rezvani, D. Overstreet, and Y. Lee, Attenuation of alcohol intake by Ibogaine in three strains of alcohol-preferring rats, Pharmacology Biochemistry and Behavior, vol.52, issue.3, pp.615-635, 1995.
DOI : 10.1016/0091-3057(95)00152-M

T. K. Brown, Ibogaine in the Treatment of Substance Dependence, Current Drug Abuse Reviews, vol.6, issue.1, pp.3-16, 2013.
DOI : 10.2174/15672050113109990001

K. R. Alper, H. S. Lotsof, G. M. Frenken, D. J. Luciano, and J. Bastiaans, Treatment of acute opioid withdrawal with ibogaine, Am. J. Addict, vol.8, pp.234-276, 1999.

H. S. Lotsof, Rapid method for interrupting the narcotic addiction syndrome, 1985.

J. Delourmé-houdé, Contribution à l'étude de l'iboga (Tabernanthe iboga H.Bn), Ann. Pharm. Fra, vol.4, pp.30-36, 1946.

G. A. Cooper, R. Kronstrand, and P. Kintz, Society of Hair Testing guidelines for drug testing in hair, Forensic Science International, vol.218, issue.1-3, pp.20-24, 2012.
DOI : 10.1016/j.forsciint.2011.10.024

R. Hamet, . Le-problème-du-vrai, . Des, and . Iboga, In: Revue de botanique appliquée et d'agriculture coloniale, 20e année, bulletin n°224, Thesis Doct. Unfu. (Pharm.), pp.251-62, 1944.

P. Rathi, R. Kumari, S. Chatrasal, S. S. Rajput, and . Sawhney, Therapeutic characteristics of Rauvolfia serpentine, Int, J. Pharm. Sci, vol.2, pp.1038-1080, 2013.

R. Kumari, B. Rathi, A. Rani, and S. Bhatnagar, Rauvolfia serpentina L. Benth. ex Kurz.: phytochemical, pharmacological and therapeutic aspects, Int, J. Pharm. Sci. Rev, vol.23, pp.348-55, 2013.

R. Vanbinst, J. Koenig, V. D. Fazio, and A. Hassoun, Bile analysis of drugs in postmortem cases, Forensic Science International, vol.128, issue.1-2, pp.35-40, 2002.
DOI : 10.1016/S0379-0738(02)00161-5

R. Regenthal, M. Krueger, C. Koeppel, and R. Preiss, Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs, Journal of Clinical Monitoring and Computing, vol.15, issue.7/8, pp.529-573, 1999.
DOI : 10.1023/A:1009935116877

A. R. Maass, B. Jenkins, Y. Shen, and P. Tannenbaum, H-reserpine in man, Clinical Pharmacology & Therapeutics, vol.10, issue.3, pp.366-71, 1969.
DOI : 10.1002/cpt1969103366

S. Mehrotra, M. K. Goel, V. Srivastava, and L. U. Rahman, Hairy root biotechnology of Rauwolfia serpentina: a potent approach for the production of pharmaceutically important terpenoid indole alkaloids, Biotechnology Letters, vol.90, issue.2, pp.37-253, 2015.
DOI : 10.1007/s00253-011-3228-0

S. Nammi, K. M. Boini, S. Koppula, and S. Sreemantula, Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide, Canadian Journal of Physiology and Pharmacology, vol.83, issue.6, pp.509-524, 2005.
DOI : 10.1139/y05-039

G. Rudnick, S. S. Steiner-mordoch, H. Fishkes, Y. Stern-bach, and S. Schuldiner, Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter, Biochemistry, vol.29, issue.3, pp.29-603, 1990.
DOI : 10.1021/bi00455a002

B. B. Hoffman, F. M. Williams, D. E. Golan, A. H. Tashjian, and E. J. Armstrong, Adrenergic pharmalogy Principles of pharmacology: the pathophysiologic basis of drug therapy. 3 rd, pp.132-142, 2011.

DOI : 10.1136/hrt.11.4.350

R. E. Stitzel, The biological fate of reserpine, Pharmacol. Rev, vol.28, pp.179-208, 1976.

J. M. Good and D. C. , toxicity in a dog, Journal of Veterinary Emergency and Critical Care, vol.100, issue.(suppl 1), pp.654-662, 2008.
DOI : 10.1111/j.1476-4431.2008.00367.x

R. C. Baselt, Disposition of toxic drugs and chemicals in man, 10 th, p.2211, 2014.

S. Rolf, H. J. Bruns, T. Wichter, P. Kirchhof, M. Ribbing et al., The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol, European Heart Journal, vol.24, issue.12, pp.24-1104, 2003.
DOI : 10.1016/S0195-668X(03)00195-7

V. Chávarri, Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome, Pacing. Clin. Electrophysiol, vol.23, pp.407-416, 2000.

J. C. Jornod and J. A. Barrelet, Suicidal attempt by overdosage of ajmaline, American Heart Journal, vol.70, issue.5, pp.719-739, 1965.
DOI : 10.1016/0002-8703(65)90402-3

V. Medina-ravell, L. Rodriguez-salas, I. J. Mendoza, and A. Castellanos, Nonfatal ajmaline cardiotoxicity, Nonfatal ajmaline cardiotoxicity, pp.958-967, 1984.
DOI : 10.1016/0002-9149(84)90536-8

H. J. Wellens, F. W. Bar, and E. J. Vanagt, Death after ajmaline administration, The American Journal of Cardiology, vol.45, issue.4, pp.45-905, 1980.
DOI : 10.1016/0002-9149(80)90139-3

C. Köppel, U. Oberdisse, and G. Heinemeyer, CLINICAL COURSE AND OUTCOME IN CLASS IC ANTIARRHYTHMIC OVERDOSE, Journal of Toxicology: Clinical Toxicology, vol.80, issue.4, pp.28-433, 1990.
DOI : 10.1016/0024-3205(89)90424-4

C. Anderson, D. Anderson, N. Harre, and N. Wade, Case Study: Two Fatal Case Reports of Acute Yohimbine Intoxication, Journal of Analytical Toxicology, vol.37, issue.8, pp.611-615, 2013.
DOI : 10.1093/jat/bkt057

P. Le-corre, G. Dollo, F. Chevanne, and R. L. Verge, Biopharmaceutics and metabolism of yohimbine in humans, Eur, J. Pharm. Sci, vol.9, pp.79-84, 1999.

C. H. Linden, W. P. Vellman, and B. Rumack, Yohimbine: A new street drug, Annals of Emergency Medicine, vol.14, issue.10
DOI : 10.1016/S0196-0644(85)80249-3

A. Karioti, E. Giocaliere, C. Guccione, G. Pieraccini, E. Gallo et al., Combined HPLC-DAD???MS, HPLC???MSn and NMR spectroscopy for quality control of plant extracts: The case of a commercial blend sold as dietary supplement, Journal of Pharmaceutical and Biomedical Analysis, vol.88, pp.88-95, 2014.
DOI : 10.1016/j.jpba.2013.07.040